Association of antibiotic use with rheumatoid arthritis: A Mendelian randomization study

Chang Liu1, Zhijun Ma1, Xin Zhao2

  • 1School of Acupuncture-Moxibustion and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.

Medicine
|January 31, 2025
PubMed

Insights

This study investigated the causal link between antibiotic use and rheumatoid arthritis (RA) using Mendelian randomization. Results indicate no direct causal relationship between antibiotic exposure and RA development.

Area of Science:

  • Genetics
  • Rheumatology
  • Pharmacology

Background:

  • Observational studies suggest a link between antibiotic use and rheumatoid arthritis (RA), but causality is unproven.
  • Understanding this relationship is crucial for clinical practice and patient management.

Purpose of the Study:

  • To investigate the potential causal relationship between the use of 12 different antibiotics and the development of rheumatoid arthritis (RA).
  • To utilize Mendelian randomization (MR) analysis in a European population to assess causality.

Main Methods:

  • Employed Mendelian randomization (MR) using pooled genome-wide association study (GWAS) data from European populations.
  • Utilized univariate and multivariate MR analyses, including inverse variance weighting, MR-Egger, and weighted median methods.
  • Performed comprehensive sensitivity analyses to ensure the robustness of the findings.

Main Results:

  • Univariate MR suggested a potential positive association between tetracycline use and RA (OR=1.013, P=0.028).
  • However, multivariate MR analysis did not support a causal association between tetracycline use and RA.
  • No causal link was identified for the other 11 antibiotics examined.

Conclusions:

  • The study findings do not support a direct causal relationship between antibiotic use and rheumatoid arthritis (RA).
  • These results may help alleviate clinical concerns regarding antibiotic exposure and RA development.
  • Further MR studies with larger datasets and detailed information are warranted to confirm these findings.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
Antibiotic Selection00:57

Antibiotic Selection

Overview
52.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141